Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 ...

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are trading lower Tuesday after initially jumping after the company ...

Noble Capital Markets has recently initiated Tonix Pharmaceuticals Holding Corp (TNXP) stock to Outperform rating, as announced on April 18, 2022, according to Finviz. Earlier, on April 18, 2019, ROTH ...

FDA is expected to assign a Prescription Drug User Fee Act (PDUFA) target action date and announce whether Priority Review ...

Tonix Pharmaceuticals (TNXP) announced that the U.S. Food and Drug Administration, FDA, has accepted the filing of its New Drug Application, ...

Tonix Pharmaceuticals Holding Corp (TNXP) stock saw a modest uptick, ending the day at $0.24 which represents a slight increase of $0.01 or 4.35% from the prior close of $0.23. The stock opened at $0.

Equities researchers at StockNews.com assumed coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Get Free Report) in a report released on Sunday. The firm set a “sell” rating on the stock.

Tonix Pharma ( (TNXP) ) has provided an announcement.

(Nasdaq: TNXP) announced that the US Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for ...

Shares of Corvus Pharmaceuticals, Inc. CRVS +18.3% + Free Alerts rose sharply in today's pre-market trading after the company ...

CHATHAM, N.J. - Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), a biopharmaceutical company, announced findings from a study indicating that its new vaccine candidate TNX-801... ByInvesting.com ...